Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stephanie H. Farnia"'
Autor:
Charles F. LeMaistre, M. Boo, Krishna V. Komanduri, Richard T. Maziarz, Mark McClellan, Christopher Bredeson, Stephanie H. Farnia, James Gajewski, Parameswaran Hari, Michael Lill, Navneet S. Majhail
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:4-12
Patient-centered medical home models are fundamental to the advanced alternative payment models defined in the Medicare Access and Children's Health Insurance Plan Reauthorization Act (MACRA). The patient-centered medical home is a model of healthcar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f12943a32e8c9aef35deb567b87da82
https://doi.org/10.1016/j.bbmt.2017.09.012
https://doi.org/10.1016/j.bbmt.2017.09.012
Autor:
Stephanie H. Farnia, Lih Wen Mau, Wael Saber, Kristen C. Edsall, Linda J. Burns, Ellen M. Denzen, Jaime M. Preussler, Christa Meyer, David J. Vanness, Navneet S. Majhail
The primary aim of this study was to describe healthcare costs and utilization during the first year after a diagnosis of acute myeloid leukemia (AML) for privately insured non-Medicare patients in the United States (US) aged 50-64 years who were tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2d918459b8cc01e2a8c7d94907f87fe
https://europepmc.org/articles/PMC5497312/
https://europepmc.org/articles/PMC5497312/
Publikováno v:
Journal of Oncology Practice. 10:e196-e200
Variation in Medicaid policies among states may lead to differences in coverage for complex treatments. This article uses hematopoietic cell transplantation (HCT), an established treatment for patients with hematologic cancers, as a case study to hig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d19edf710e8c1f330f1198783fc73ed1
https://doi.org/10.1200/jop.2013.001155
https://doi.org/10.1200/jop.2013.001155
Autor:
Stephanie H. Farnia, Ellen M. Denzen, Wael Saber, Jaime M. Preussler, Kristen C. Edsall, Linda J. Burns, David J. Vanness, Navneet S. Majhail, Alicia Silver, Lih Wen Mau, Christa Meyer
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(10)
There is an increasing need for the development of approaches to measure quality, costs, and resource utilization patterns among allogeneic hematopoietic cell transplantation (HCT) patients. Administrative claims data provide an opportunity to examin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd8501c2d703884c7e4662d9925d7513
https://pubmed.ncbi.nlm.nih.gov/27184624
https://pubmed.ncbi.nlm.nih.gov/27184624
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(8)
Bundled payments for hematopoietic cell transplantation (HCT) have long been accepted by both commercial health insurance providers and transplant centers, effectively outpacing the use of this payment model elsewhere in health care. As with the rest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d926491e2304453afd6448935f4ffde
https://pubmed.ncbi.nlm.nih.gov/25889042
https://pubmed.ncbi.nlm.nih.gov/25889042
Autor:
James L. Omel, David I. Marks, Wael Saber, Christopher Bredeson, Stephanie H. Farnia, Jeanne Palmer, Charles F. LeMaistre, Paul A. Carpenter, Bipin N. Savani, Sergio Giralt, Stephen Crawford, Richard E. Champlin, Paul J. Orchard, Paul Veys, Navneet S. Majhail
Publikováno v:
Biology of Blood and Marrow Transplantation. (11):1863-1869
Approximately 20,000 hematopoietic cell transplantation (HCT) procedures are performed in the United States annually. With advances in transplantation technology and supportive care practices, HCT has become safer, and patient survival continues to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52807cb2064d10b546e3dd9b809d424c